DOSH, Laura
 Distribuzione geografica
Continente #
EU - Europa 54
AS - Asia 45
NA - Nord America 22
Totale 121
Nazione #
IT - Italia 43
US - Stati Uniti d'America 22
LB - Libano 19
SG - Singapore 15
DE - Germania 6
FI - Finlandia 3
HK - Hong Kong 3
IN - India 3
JP - Giappone 3
CN - Cina 1
ES - Italia 1
GB - Regno Unito 1
MY - Malesia 1
Totale 121
Città #
Singapore 12
Ashburn 8
Cagliari 8
Palermo 6
Ludwigshafen am Rhein 5
Beirut 4
Milan 4
Rome 4
Central 3
Baltimore 2
Lappeenranta 2
Padova 2
Shimla 2
Tokyo 2
Barakaldo 1
Beijing 1
Camerino 1
Capaci 1
Columbus 1
Helsinki 1
Islington 1
Kuala Lumpur 1
Lamezia Terme 1
Richland 1
Santa Clara 1
Takasago 1
Vadodara 1
Washington 1
Totale 78
Nome #
THE CHAPERONE SYSTEM IN SALIVARY GLAND DEVELOPMENT 37
THE MECHANISM AND POTENTIAL THERAPEUTIC EFFECTS OF CYCLOPHILIN AND SYNDECAN 1 IN INFLAMMATORY BOWEL DISEASE: CAN THIS COMBINATION TREATMENT DUPLICATE THE ANTIINFLAMMATORY EFFECT OF CYCLOSPORINE WITHOUT ITS IMMUNOSUPPRESSIVE EFFECT? 28
Nerve growth factor and burn wound healing: Update of molecular interactions with skin cells 22
Highlights on two decades with microbiota and inflammatory bowel disease from etiology to therapy 20
THE MECHANISM AND POTENTIAL THERAPEUTIC EFFECTS OF CYCLOPHILIN AND SYNDECAN 1 IN INFLAMMATORY BOWEL DISEASE: CAN THIS COMBINATION TREATMENT DUPLICATE THE ANTIINFLAMMATORY EFFECT OF CYCLOSPORINE WITHOUT ITS IMMUNOSUPPRESSIVE EFFECT? 18
The Mechanism and Potential Therapeutic Effects of Cyclosporin, Cyclophilin, Probiotics and Syndecan-1 in an Animal Model of Inflammatory Bowel Disease 15
Lack of Syndecan‑1 promotes the pathogenesis of experimental rheumatoid arthritis 9
Probiotics, gut microbiome, and cardiovascular diseases: An update 9
Totale 158
Categoria #
all - tutte 1.308
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.308


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2022/202334 0 0 0 0 1 0 8 0 0 7 12 6
2023/202489 11 4 15 13 4 5 7 20 2 1 6 1
2024/202535 14 7 4 9 1 0 0 0 0 0 0 0
Totale 158